MAPT and Alzheimer disease: Indeed, the olfactory dysfunction is among the earliest features of AD and FTD [51,52], and the accumulation of aggregated tau protein in this brain structure correlates with the progression and the severity of the disease in other brain regions [53], underscoring the potential utility of olfactory tissue in the early diagnosis of AD and FTD.